Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

@article{Ingallinella2005VectoredGA,
  title={Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.},
  author={Paolo Ingallinella and Danilo Riguera Casimiro and William A. Schleif and Fubao Wang and Mary-Ellen Davies and Zhi-qiang Zhang and Tong-Ming Fu and Adam C. Finnefrock and Larry K Handt and Michael P. Citron and Gwendolyn J. Heidecker and Aimin Tang and Minchun Chen and Kimberley A. Wilson and Lori S Gabryelski and Michael J. McElhaugh and Anthony Carella and Cheryl A. Moyer and Lingyi Huang and Salvatore Vitelli and Deepa K Patel and Jing Lin and Emilio A. Emini and John W. Shiver},
  journal={Journal of virology},
  year={2005},
  volume={79 19},
  pages={
          12321-31
        }
}
Simian-human immunodeficiency virus (SHIV) challenge studies in rhesus macaques were conducted to evaluate the efficacy of adenovirus-based vaccines in the context of different major histocompatibility complex class I genetic backgrounds and different vaccine compositions. Mamu-A*01 allele-negative rhesus monkeys were immunized with one of the following vaccine constructs: (i) replication-defective recombinant adenovirus type 5 (Ad5) expressing human immunodeficiency virus type 1 (HIV-1) Tat… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 33 CITATIONS

Similar Papers